Full-Time

Associate Portfolio Manager

Posted on 10/2/2024

Maven Securities

Maven Securities

201-500 employees

Multi-strategy trading and market making firm

No salary listed

Entry, Junior

London, UK

Position requires onsite presence in London.

Category
Asset Management
Investment Banking
Finance & Banking
Required Skills
Management
Requirements
  • Research, development, implementation and management of strategies, as directed
  • Management of the life cycle of all ideas
  • Close collaboration on ideas with existing Portfolio Managers
  • Comply with all applicable Compliance policies, procedures, laws and regulations.
Responsibilities
  • Research, development, implementation and management of strategies, as directed
  • Management of the life cycle of all ideas
  • Close collaboration on ideas with existing Portfolio Managers
  • Comply with all applicable Compliance policies, procedures, laws and regulations.

Maven Securities operates in the financial sector as a multi-strategy trading and market making firm. It uses both fundamental and quantitative methods to trade across global markets. The firm only uses its own capital, which helps align its interests with those of its clients and allows for greater operational flexibility. Technology plays a crucial role in Maven's operations, as it incorporates advancements in computer learning and processing power to improve trading efficiency from the initial trade to settlement. Maven serves a variety of clients, including institutional investors, by providing liquidity and ensuring efficient market execution. What sets Maven apart from its competitors is its focus on meticulous execution and conservative risk management, which helps maintain sustainable profitability. The firm's goal is to capitalize on market inefficiencies and leverage its technological capabilities to generate revenue through trading profits and market making activities.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased machine learning adoption enhances Maven's quantitative trading capabilities.
  • Alternative data sources provide new insights for market predictions, benefiting Maven.
  • Advancements in quantum computing could solve complex trading optimization problems for Maven.

What critics are saying

  • Competition from firms with similar technology could erode Maven's market share.
  • Rapid technological changes may render Maven's current systems obsolete.
  • Intensifying regulatory scrutiny could increase compliance costs for Maven.

What makes Maven Securities unique

  • Maven Securities uses proprietary capital, ensuring alignment of interests and flexibility.
  • The firm integrates advancements in computer learning to enhance trading operations.
  • Maven's multi-strategy approach combines fundamental and quantitative trading across global markets.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401K Scheme

25 Days Annual Leave plus public holidays

Healthcare, Dental & Vision

Employee Volunteering Opportunities

Annual Discretionary Bonus

Company News

MarketBeat
Mar 2nd, 2025
Rithm Capital Corp. (NYSE:RITM) Shares Sold by Y Intercept Hong Kong Ltd

Soros Fund Management LLC acquired a new stake in Rithm Capital in the 3rd quarter valued at about $23,835,000.

MarketBeat
Jan 19th, 2025
Rithm Capital Corp. (NYSE:RITM) Receives $12.94 Consensus Price Target from Brokerages

Finally, Maven Securities LTD purchased a new stake in Rithm Capital in the 3rd quarter worth about $11,350,000.

ETF Daily News
Dec 18th, 2024
Wellington Management Group LLP Cuts Stake in Wave Life Sciences Ltd. (NASDAQ:WVE)

Maven Securities LTD purchased a new stake in Wave Life Sciences in the third quarter worth $6,970,000.

MarketBeat
Dec 18th, 2024
Charles Schwab Investment Management Inc. Invests $1.16 Million in Alumis Inc. (NASDAQ:ALMS)

Maven Securities LTD purchased a new stake in Alumis in the second quarter worth approximately $332,000.

Slater Sentinel
Dec 9th, 2024
Point72 DIFC Ltd Takes $134,000 Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)

Maven Securities LTD acquired a new stake in Relay Therapeutics in the third quarter valued at $2,389,000.

INACTIVE